Cgp 19984 is a thiazolidinedione derivative that inhibits luteinizing hormone secretion and has antitumor effects. CGP 19984 significantly inhibited growth of the androgen-dependent Dunning R3327 rat prostate adenocarcinoma. The ability of CGP 19984 to suppress gonadal function and to inhibit tumor growth suggests that this drug may have potential clinical application in the treatment of both hormone-dependent and -independent prostate and breast cancers.
MedKoo Cat#: 524618
Name: Cgp 19984
CAS#: 524618
Chemical Formula: C13H18N4NaO6PS2
Exact Mass:
Molecular Weight: 444.40
Elemental Analysis: C, 35.13; H, 4.08; N, 12.61; Na, 5.17; O, 21.60; P, 6.97; S, 14.43
The following data is based on the product molecular weight 444.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |